PTC Therapeutics Inc. buy Truist Financial Co.
Start price
29.07.25
/
50%
€42.80
Target price
29.07.26
€74.16
Performance (%)
44.81%
Price
17.04.26
€60.08
Summary
This prediction is currently active. With a performance of 44.81% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 29.07.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 3.266% | 3.266% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Truist_Financial_Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Truist Financial Corporation from $80.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.60
17.06.25
17.06.25
€69.25
17.06.26
17.06.26
37.16%
17.04.26
17.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€42.12
18.09.24
18.09.24
40.35%
19.09.24
19.09.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.60
16.08.23
16.08.23
€59.68
16.08.24
16.08.24
-20.77%
17.08.24
17.08.24